🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial will assess the safety and efficacy of omarigliptin (MK-3102) co...
Status
Terminated
Location
Multiple Locations
Start Date
2013-07-08
Trial ID
NCT01863667
Treatments Being Tested
The purpose of this study is to evaluate the effect of JTT-851 on diabetes ...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01699737
Treatments Being Tested
This study will evaluate the efficacy and safety of vildagliptin 50 mg bid ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-10
Trial ID
NCT01233622
Treatments Being Tested
Primary objective of this study is to confirm the efficacy of HOE490 O (gli...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-05
Trial ID
NCT00924573
Treatments Being Tested
Diabetic peripheral neuropathy(DPN) is a length dependent axonal neuropathy...
Status
Unknown
Location
Department of Endocrinology, PGIMER
Start Date
2022-05-01
Trial ID
NCT05162690
Treatments Being Tested
The purpose of this study is to demonstrate the efficacy and safety of vild...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04
Trial ID
NCT01357252
Treatments Being Tested
The purpose of this study is to determine the effect of pioglitazone, once ...
Status
Completed
Location
Multiple Locations
Start Date
2006-12
Trial ID
NCT00770952
Treatments Being Tested
This study is being carried out to see if dapagliflozin and dapagliflozin p...
Status
Completed
Location
Research Site
Start Date
2015-09-21
Trial ID
NCT02471404
The purpose of this study is to assess the safety and efficacy of omariglip...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-05
Trial ID
NCT01717313
Treatments Being Tested
This is a safety and efficacy study of ertugliflozin (MK-8835/PF-04971729) ...
Status
Completed
Location
Multiple Locations
Start Date
2014-03-12
Trial ID
NCT02036515